近十年全球肺癌放疗研究现状及发展趋势——基于Web of Science文献计量学分析

doi:10.3760/cma.j.cn113030-20200331-00147

摘要
图/表
参考文献(21)
相关文章 (15)
点击分布统计
下载分布统计

全文: PDF (0 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS) 背景资料

摘要目的通过对肺癌放疗相关文献的计量学分析,探索近10年来该领域研究现状和发展趋势。方法以Web of Science核心合集为数据来源,结合CiteSpace软件的可视化功能,采用文献计量学方法分析2010-2019年肺癌放疗研究的文献发表情况,期刊、作者、机构、国家分布情况,关键词共现及聚类情况。结果近10年来,该领域文献发表量整体呈逐年上升趋势;发文量最多的期刊为International Journal of Radiation Oncology·Biology·Physics;发文量最多的作者、机构均来自美国;立体定向放疗已成为目前该领域的研究热点,立体定向放疗与免疫治疗的联合应用可能成为今后发展趋势。结论近10年来,国内外放疗领域研究稳步发展,形成了一定的研究方向和发展趋势,出现一些核心机构及核心作者,但可能因全球放疗技术发展不平衡,国际间交流与合作有待加强。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	段和新
	向志碧
	彭海芹
	周蓉蓉

关键词 ：肺肿瘤/放射疗法, 文献计量学, 可视化分析

Abstract：Objective To investigate the research status and development trend of radiotherapy for lung cancer in recent 10 years through the bibliometric analysis of relevant literature. Methods Taking the core collection of Web of Science as the data source,combined with the visualization function of Cite Space software,bibliometric methods were adopted to analyze the literature publication,distribution of journals,authors,institutions and countries,the literature co-citation,keyword co-occurrence and clustering of the lung cancer radiotherapy research from 2010 to 2019. Results In recent 10 years,the amount of literature published in this field has been on the rise year by year. International Journal of Radiation Oncology Biology Physics was the journal with the largest number of publications. The authors and organizations with the most articles were all from the United States. Stereotactic radiotherapy has become a research hot spot in this field,and the combination of immunotherapy and stereotactic radiotherapy may become a novel development trend in the future. Conclusions In the past 10 years,the research on radiotherapy has been developing steadily at home and abroad,forming a certain research direction and development trend. Some core institutions and core authors have appeared. However, international exchange and cooperation remain to be strengthened probably due to the unbalanced development of global radiotherapy technology.

Key words： Lung neoplasm/radiotherapy Bibliometrics Visualization analysis

收稿日期: 2020-03-31

基金资助:国家自然科学基金(81770928);湖南省自然科学基金(2018JJ2626)

通讯作者: 周蓉蓉,Email:664990095@qq.com

引用本文:

段和新,向志碧,彭海芹等. 近十年全球肺癌放疗研究现状及发展趋势——基于Web of Science文献计量学分析[J]. 中华放射肿瘤学杂志, 2020, 29(6): 401-406.

Duan Hexin,Xiang Zhibi,Peng Haiqin et al. Research status and development trend of global radiotherapy for lung cancer in recent 10 years——bibliometric analysis based on Web of Science[J]. Chinese Journal of Radiation Oncology, 2020, 29(6): 401-406.

链接本文:

http://journal12.magtechjournal.com/Jweb_fszlx/CN/10.3760/cma.j.cn113030-20200331-00147 或 http://journal12.magtechjournal.com/Jweb_fszlx/CN/Y2020/V29/I6/401

[1] Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6):394-424. DOI:10.3322/caac.21492.
[2] Kong FM, Zhao J, Wang J, et al. Radiation dose effect in locally advanced non-small cell lung cancer[J]. J Thorac Dis, 2014, 6(4):336-347. DOI:10.3978/j.issn.2072-1439.2014.01.23.
[3] 高俊宽. 文献计量学方法在科学评价中的应用探讨[J]. 图书情报知识, 2005,(2):14-17. DOI:10.3969/j.issn.1003-2797.2005.02.004.
Gao JK. Application of Bibliometrics Methods in Scientific Evaluation[J]. Document, Informaiton& Knowledge, 2005,(2):14-17. DOI:10.3969/j.issn.1003-2797.2005.02.004.
[4] 陈悦, 陈超美, 刘则渊, 等. CiteSpace知识图谱的方法论功能[J]. 科学学研究, 2015, 33(2):242-253. DOI:10.3969/j.issn.1003-2053.2015.02.009.
Chen Y, Chen CM, Liu ZY, et al. The methodology function of CiteSpace mapping knowledge domains[J]. Studies in Science of Science, 2015, 33(2):242-253. DOI:10.3969/j.issn.1003-2053.2015.02.009.
[5] 邹建军, 苏珊, 张贤兰, 等.2004年-2013年肺癌患病风险基因相关临床研究文献的计量学分析[J]. 分子诊断与治疗杂志, 2015, 7(4):236-240. DOI:10.3969/j.issn.1674-6929.2015.04.004.
Zou JJ, Su S, Zhang XL, et al. Bibliometrics analysis of clinical research literature on lung cancer predisposing genes from 2004 to 2013[J]. Journal of Molecular Diagnostics and Therapy, 2015, 7(4):236-240. DOI:10.3969/j.issn.1674-6929.2015.04.004.
[6] 应倩, 夏庆民, 狄笛, 等. 基于科学引文索引数据库的肺癌转化医学研究文献计量学分析[J]. 转化医学杂志, 2015(1):16-20. DOI:10.3969/j.issn.2095-3097.2015.01.005.
Ying Q, Xia QM, Di D, et al. An analysis for status of lung cancer translational research based on science citation index database[J]. Translational Medicine Journal, 2015,(1):16-20. DOI:10.3969/j.issn.2095-3097.2015.01.005.
[7] Ho YS, Nakazawa K, Sato S, et al. Cisplatin for small cell lung cancer:associated publications in Science Citation Index Expanded[J]. OncolLett, 2013, 5(2):684-688. DOI:10.3892/ol.2012.1029.
[8] 樊东升, 凌曦, 赵志刚, 等. 非小细胞肺癌靶向治疗研究的分析[J]. 中国临床药理学杂志, 2018, 34(14):1707-1709. DOI:10.13699/j.cnki.1001-6821.2018.14.035.
Fan DS, Ling X, Zhao ZG, et al. Analysis of the targeted therapy of non-small cell lung cancer[J]. The Chinese Journal of Clinical Pharmacology, 2018, 34(14):1707-1709. DOI:10.13699/j.cnki.1001-6821.2018.14.035.
[9] He XR, Han SY, Li PP. Recent highlights of Chinese medicine for advanced lung cancer[J]. Chin J Integr Med, 2017, 23(5):323-330. DOI:10.1007/s11655-016-2736-2.
[10] Haasbeek CJ, Lagerwaard FJ, Antonisse ME, et al. stage Ⅰ nonsmall cell lung cancer in patients aged> OR= 75 years:outcomes after stereotactic radiotherapy[J]. Cancer, 2010, 116(2):406-414. DOI:10.1002/cncr.24759.
[11] Li XP, Xiao JP, Chen XJ, et al. Fractionated stereotactic radiotherapy for small-cell lung cancer patients with brain metastases[J]. J Cancer Res Ther, 2014, 10(3):597-602. DOI:10.4103/0973-1482.137964.
[12] Singh D, Chen Y, Hare MZ, et al. Local control rates with five-fraction stereotactic body radiotherapy for oligometastatic cancer to the lung[J]. J Thorac Dis, 2014, 6(4):369-374. DOI:10.3978/j.issn.2072-1439.2013.12.03.
[13] Yamamoto T, Jingu K, Shirata Y, et al. Outcomes after stereotactic body radiotherapy for lung tumors, with emphasis on comparison of primary lung cancer and metastatic lung tumors[J]. BMC Cancer, 2014, 14:464. DOI:10.1186/1471-2407-14-464.
[14] Agolli L, Valeriani M, Nicosia L, et al. Stereotactic ablative body radiotherapy (SABR) in pulmonary oligometastatic/oligorecurrent non-small cell lung cancer patients:a new therapeutic approach[J]. Anticancer Res, 2015, 35(11):6239-6245.
[15] Celik E, Semrau R, Baues C, et al. Robot-assisted extracranial stereotactic radiotherapy of adrenal metastases in oligometastatic non-small cell lung cancer[J]. Anticancer Res, 2017, 37(9):5285-5291. DOI:10.21873/anticanres.11954.
[16] Desideri I, Francolini G, Scotti V, et al. Benefit of ablative versus palliative-only radiotherapy in combination with nivolumab in patients affected by metastatic kidney and lung cancer[J]. ClinTransl Oncol, 2019, 21(7):933-938. DOI:10.1007/s12094-018-02005-7.
[17] Shukuya T, Takahashi T, Naito T, et al. Continuous EGFR-TKI administration following radiotherapy for non-small cell lung cancer patients with isolated CNS failure[J]. Lung Cancer, 2011, 74(3):457-461. DOI:10.1016/j.lungcan.2011.04.007.
[18] Inomata M, Shukuya T, Takahashi T, et al. Continuous administration of EGFR-TKIs following radiotherapy after disease progression in bone lesions for non-small cell lung cancer[J]. Anticancer Res, 2011, 31(12):4519-4523.
[19] Herter-Sprie GS, Koyama S, Korideck H, et al. Synergy of radiotherapy and PD-1 blockade in Kras-mutant lung cancer[J]. JCI Insight, 2016, 1(9):e87415. DOI:10.1172/jci.insight.87415.
[20] 赵蓉英, 许丽敏. 文献计量学发展演进与研究前沿的知识图谱探析[J]. 中国图书馆学报, 2010, 36(5):60-68.
Zhao RY, Xu LM. An analysis of the knowledge map of the development evolution and research frontier of bibliometrics[J]. Journal of Library Science in China, 2010, 36(5):60-68.
[21] 李爱群, 黄玉舫, 邱均平. 我国学术期刊文献计量评价体系的客观性与评价结果的准确性探讨[J]. 中国科技期刊研究, 2009, 20(4):609-613.
Li AQ, Huang YF, Qiu JP. On objectivity and accuracy in evaluating Chinese academic journal documents by bibliometric system[J]. Chinese Journal of Scientificand Technical Periodical, 2009, 20(4):609-613.